CI stock verdict - Avoid
CI
The Cigna Group
AVOIDHealthcare
$272.01
Fundamentals below bar
⚠️ Earnings-multiple levels suppressed — the model fair value is implausibly far above the market price (likely cyclical-peak or one-off earnings). Judge this name manually.
VALUE83
GROWTH21
QUALITY47
TECHNICAL—
TRUST SCORE
90High
confidence in this read — data completeness, earnings quality & coverage
Technicals: insufficient price history
PROS
- Reasonable forward P/E of 8.1× on analyst estimates
- Strong return on equity of 15.1% (TTM)
- Revenue grew 15.3%/yr on average over the last 3 years
- TTM EPS grew 83.0% year-over-year
- Balance sheet holds net cash (cash exceeds total debt)
CONS
- Earnings-based fair value is implausible (likely peak or one-off earnings) — the valuation model abstained from price levels
- Thin net margin of 2.1% (3-yr avg)
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
EARNINGS QUALITY · we check the accounting so you don't have to
✓Operating cash flow is 160% of net income — profit is backed by real cash
Analysis as of 2026-09-25 · price live, fundamentals from latest filings
Congress Trading — last 90 days
See what senators are buying and selling on CI. Sign in to unlock.
📊 Options Flow — Put/Call Ratio
FAQ
Why is CI rated Avoid?
CI (The Cigna Group) is rated Avoid because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Fundamentals below bar. Reasonable forward P/E of 8.1× on analyst estimates and Strong return on equity of 15.1% (TTM)
Why are CI's price levels hidden?
The model withheld price levels for CI because the earnings anchor looks unreliable or incomplete. The page explicitly flags that the fair-value math should be verified manually.
What should I watch before acting on CI?
Watch the trust score of 90, the earnings-quality checks, and any red flags. Earnings-based fair value is implausible (likely peak or one-off earnings) — the valuation model abstained from price levels and Thin net margin of 2.1% (3-yr avg)